Send to

Choose Destination
Science. 2019 Nov 1;366(6465). pii: eaan4673. doi: 10.1126/science.aan4673.

Clonal hematopoiesis in human aging and disease.

Author information

Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Department of Medical Oncology, Howard Hughes Medical Institute, Boston, MA.
Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.


As people age, their tissues accumulate an increasing number of somatic mutations. Although most of these mutations are of little or no functional consequence, a mutation may arise that confers a fitness advantage on a cell. When this process happens in the hematopoietic system, a substantial proportion of circulating blood cells may derive from a single mutated stem cell. This outgrowth, called "clonal hematopoiesis," is highly prevalent in the elderly population. Here we discuss recent advances in our knowledge of clonal hematopoiesis, its relationship to malignancies, its link to nonmalignant diseases of aging, and its potential impact on immune function. Clonal hematopoiesis provides a glimpse into the process of mutation and selection that likely occurs in all somatic tissues.


Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center